Uncategorized - malecare.org

On the Horizon – Estrogen Receptor Modulator Reduces Bone Complications from Androgen Deprivation Therapy for Prostate Cancer

A multi-center Phase III study discussed at the 2009 meeting of the American Urological Association,[1] has demonstrated that the risk for bone fractures in men on androgen deprivation therapy (ADT) can be reduced by using toremifene (Acapodene). Men, fighting advanced prostate cancer, often receive long-term ADT, which along with other side effects will increase their [...]

By Malecare|2017-10-19T10:54:30-04:00September 26th, 2009|Advanced Prostate Cancer, Bone Mineral Density, Clinical Trials, Clinical Trials, Hormone Therapy, On The Horizon, Research, Uncategorized, Understanding APC|2 Comments

Confirming Hormone Therapy Increases The Risk for Heart Diseases

Confirming a belief of many of us, new research has found that hormone therapy (endocrine therapy or ADT) is associated with a very large increased risk of developing various major heart problems. This research also tells us that some therapy options have a higher risk profile than others. At Europe's biggest cancer congress, ECCO 15 [...]

By Malecare|2009-09-24T10:37:40-04:00September 24th, 2009|Advanced Prostate Cancer, Drugs & Treatments, General Information, Hormone Therapy, Prostate Ponderings, Research, Uncategorized, Understanding APC|0 Comments

Younger Men With Advanced Prostate Cancer Have A Shorter Lifespan

Advanced prostate cancer poses a deadly paradox for younger men (aged 35 to 44 years). Younger men diagnosed with advanced prostate cancer will have a shorter remaining life span than older men who develop the disease, despite the fact that in general younger men have a much lower risk of dying from prostate cancer. Daniel [...]

By Malecare|2017-10-19T10:54:31-04:00September 23rd, 2009|Advanced Prostate Cancer, General Information, Screening, Uncategorized, Understanding APC|0 Comments

On the Horizon – Estrogen Receptor Modulator Reduces Bone Complications from Androgen Deprivation Therapy for Prostate Cancer

A multi-center Phase III study was discussed at the 2009 meeting of the American Urological Association.[1] The perliminar results of this study has demonstrated that the risk for incurring bone fractures in men on androgen deprivation therapy (ADT) is reduced when the drug toremifene (Acapodene) is administered. Men, fighting advanced prostate cancer, often receive long-term [...]

By Malecare|2017-10-19T10:54:32-04:00September 22nd, 2009|Advanced Prostate Cancer, Bone Mineral Density, Clinical Trials, Clinical Trials, Hormone Therapy, On The Horizon, Uncategorized|0 Comments

Are Men or Woman “Crushed” By Our Health Care System?

I want to discuss Michelle Obama’s recent statements in support of the president’s attempts to change the health care system in the United Sates. You do not have to worry; I am not going to go into the proposed changes and all the controversy that is whirling around the various proposals, that is a separate [...]

By Malecare|2017-10-19T10:54:32-04:00September 21st, 2009|Advanced Prostate Cancer, Advocacy, Politics of Cancer, Uncategorized|0 Comments